[Cross-cultural adaptation of the French version of the thyroid cancer-specific quality of life questionnaire: THYCA-QoL].

Adaptation transculturelle en Français du questionnaire évaluant la qualité de vie des patients opérés d’un cancer de la thyroïde : THYCA-QoL.

Journal

Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416

Informations de publication

Date de publication:
Historique:
received: 10 07 2020
revised: 24 12 2020
accepted: 04 01 2021
pubmed: 27 4 2021
medline: 15 7 2021
entrez: 26 4 2021
Statut: ppublish

Résumé

The aim of this study was to translate into French the 24 items of the THYCA-QoL questionnaire used in thyroid cancers and then to study its psychometric properties. The THYCA-QoL is a specific questionnaire for evaluating the quality of life of patients undergoing thyroid cancer surgery. It consists of 24 items and is divided into seven dimensions and six isolated questions. The translation has been carried out according to the recommendations of the EORTC. Validation of the translated version was obtained by finding a consensus of experts for each of the items. All the original questions of the questionnaire have been adapted into French. The translated questionnaire, named THYCA-CoL-fr, was tested on 60 patients (65 % female), mean age 54.5 years. All questions were well accepted and understood and no missing data were reported. Eight patients (13 %) proposed an item correction to the questionnaire. No attenuation effects (floor or ceiling) were detected. The internal structure was comparable to the original questionnaire: Cronbach α coefficients varied from 0.53 for the oropharyngeal dimension to 0.88 for the voice dimension. The scree-plot highlighted the seven dimensions of the English version. THYCA-QoL-fr is the first specific French language questionnaire to evaluate the quality of life in thyroid cancer patients undergoing surgery. These first exploratory psychometric results confirmed the conceptual similarity of the French translation and the English version.

Identifiants

pubmed: 33896584
pii: S0007-4551(21)00106-5
doi: 10.1016/j.bulcan.2021.01.009
pii:
doi:

Types de publication

Journal Article Validation Study

Langues

fre

Sous-ensembles de citation

IM

Pagination

696-704

Informations de copyright

Copyright © 2021 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

Boris Scheller (B)

Institut universitaire de la Face et du Cou, Université Côté d'Azur, 31, avenue de Valombrose, 06100 Nice, France. Electronic address: boris.scheller@gmail.com.

Joseph Santini (J)

Polyclinique Saint Georges, 2, avenue de Rimiez, 06100 Nice, France.

Amélie Anota (A)

Unité de méthodologie et de qualité de vie en oncologie, CHU Jean Minjoz, boulevard Fleming, 25030 Besançon, France.

Gilles Poissonnet (G)

Institut universitaire de la Face et du Cou, Université Côté d'Azur, 31, avenue de Valombrose, 06100 Nice, France.

Y Chateau (Y)

Département de biostatistiques, Centre Antoine-Lacassagne, Université Côté d'Azur, 33, avenue de Valombrose, 06189 Nice, France.

Renaud Schiappa (R)

Département de biostatistiques, Centre Antoine-Lacassagne, Université Côté d'Azur, 33, avenue de Valombrose, 06189 Nice, France.

Danielle Benisvy (D)

Pôle d'imagerie médecine nucléaire, Centre Antoine-Lacassagne, Université Côté d'Azur, 33, avenue de Valombrose, 06189 Nice, France.

Olivier Dassonville (O)

Institut universitaire de la Face et du Cou, Université Côté d'Azur, 31, avenue de Valombrose, 06100 Nice, France.

Alexandre Bozec (A)

Institut universitaire de la Face et du Cou, Université Côté d'Azur, 31, avenue de Valombrose, 06100 Nice, France.

Emmanuel Chamorey (E)

Département de biostatistiques, Centre Antoine-Lacassagne, Université Côté d'Azur, 33, avenue de Valombrose, 06189 Nice, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH